Loading
Mangoceuticals, Inc. Stock: price and insider trades · United States
US·Mcap US$8.3M
Mangoceuticals, Inc.: what insiders have been doing
This page follows insider dealings at Mangoceuticals, Inc. as filed with SEC (Form 4). Over the twelve months to 18 October 2026, 12 filings were filed, from 3 insiders.
Only sales appear on the open market, 4 sales in all totalling €150k, filed by 2 insiders. One trade stands out by size: a sale of €132k from Hamilton Alex P., disclosed on 26 November 2025.
With 12 filings in twelve months, the company is quieter than the median of 19 filings across the 5,808 companies we follow on the same exchange. The full history, which starts in 2023, counts no purchases against 5 sales.
Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
In the same market, recent insider purchases at GameStop Corp. and Heico Corp also feature in our signals. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
33
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€154,930
5 ops. · all time
Who traded when
BuySaleEugene M. Johnston3 sales
Alex P. Hamilton1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.37
Analyst consensus
Income statement
RevenueUS$456k
Gross profitUS$250.4k55% margin
EBITDA-US$18.8M-4126% margin
Net income-US$20.6M-4526.8% margin
Valuation
P/Book0.5x
Beta1.98
Balance sheet & cash
Market capUS$8.3M
Total debtUS$307.8k
Free Cash Flow-US$5.9M
Debt / Equity2%
Profitability & ownership
ROE-95.1%
ROA-47.0%
% insiders17.6%
% institutions5.5%
Last declaration on 6 October 2026
Declarations33 total
500,000 shares0Common StockSEC:0001493152-26-045858:0
500,000 shares0Common StockSEC:0001493152-26-045858:1
2,000,000 shares0Common StockSEC:0001493152-26-045858:2
2,000,000 shares0Common StockSEC:0001493152-26-045858:3
2,000,000 shares0Common StockSEC:0001493152-26-045858:4
100,000 shares0Common StockSEC:0001493152-26-045856:0
100,000 shares0Common StockSEC:0001493152-26-045855:0
200,000 shares0Common StockSEC:0001493152-26-011921:0
3,333 shares@ US$1.165318.3% of flowCommon StockSEC:0001493152-25-028193:0
5,000 shares@ US$1.19528.3% of flowCommon StockSEC:0001493152-25-027238:0
10,000 shares@ US$1.12853.4% of flowCommon StockSEC:0001493152-25-026923:0
125,000 shares@ US$1.22396.5% of flowCommon StockSEC:0001493152-25-025163:0
200,000 shares0Common StockSEC:0001493152-25-016352:0
100,000 shares0Common StockSEC:0001641172-25-027217:0
100,000 shares0Common StockSEC:0001641172-25-027218:0
100,000 shares0Common StockSEC:0001641172-25-027219:0
100,000 shares0Common StockSEC:0001641172-25-027216:0
60,000 shares0Common StockSEC:0001641172-25-003876:0
200,000 shares0Common StockSEC:0001641172-25-003873:0
25,000 shares0Common StockSEC:0001641172-25-003877:0
25,000 shares0Common StockSEC:0001641172-25-003875:0
25,000 shares0Common StockSEC:0001641172-25-003874:0
25,000 shares0Common StockSEC:0001493152-24-044832:0
800,000 shares0Common StockSEC:0001493152-24-034060:0
16,574 shares@ US$0.313.5% of flowCommon StockSEC:0001493152-24-025489:0
25 of 33 declarations
About Mangoceuticals, Inc.
Mangoceuticals, Inc. is a company listed on the XNAS market, specializing in the development of innovative pharmaceutical products. It focuses on enhancing health and wellness through advanced therapeutic solutions.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
